NCT05456412View on ClinicalTrials.gov

JAK Inhibition in Ulcerative Colitis

NARecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions

Colitis, Ulcerative

Interventions

OTHER

JAK inhibitor treatment

Standard care

Trial Locations (1)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Galapagos NV

INDUSTRY

lead

Leiden University Medical Center

OTHER

NCT05456412 - JAK Inhibition in Ulcerative Colitis | Biotech Hunter | Biotech Hunter